Cargando…

Editorial: JAK inhibition in autoimmune and inflammatory diseases

Detalles Bibliográficos
Autores principales:	Telliez, Jean-Baptiste, Gadina, Massimo, Ghoreschi, Kamran, Silvennoinen, Olli, Spinelli, Francesca Romana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832019/ https://www.ncbi.nlm.nih.gov/pubmed/36643918 http://dx.doi.org/10.3389/fimmu.2022.1120281

Ejemplares similares

Emerging Topical and Systemic JAK Inhibitors in Dermatology
por: Solimani, Farzan, et al.
Publicado: (2019)

JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
por: Banerjee, Shubhasree, et al.
Publicado: (2017)

Erratum to: JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
por: Banerjee, Shubhasree, et al.
Publicado: (2017)

Erratum to: JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
por: Banerjee, Shubhasree, et al.
Publicado: (2017)

Transcriptional, Epigenetic and Pharmacological Control of JAK/STAT Pathway in NK Cells
por: Scarno, Gianluca, et al.
Publicado: (2019)

JAK Inhibition Differentially Affects NK Cell and ILC1 Homeostasis
por: Vian, Laura, et al.
Publicado: (2019)

Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases
por: T. Virtanen, Anniina, et al.
Publicado: (2019)

Reversal of CD8 T-Cell–Mediated Mucocutaneous Graft-Versus-Host-Like Disease by the JAK Inhibitor Tofacitinib
por: Okiyama, Naoko, et al.
Publicado: (2014)

Editorial: Microbial and Environmental Factors in Autoimmune and Inflammatory Diseases
por: Arleevskaya, Marina I., et al.
Publicado: (2017)

Editorial: Regulation of osteoclast differentiation in autoimmune and inflammatory diseases
por: Lee, Sun-Kyeong, et al.
Publicado: (2023)

JAK Kinases in Health and Disease: An Update
por: Laurence, Arian, et al.
Publicado: (2012)

Tofacitinib Suppresses Several JAK-STAT Pathways in Rheumatoid Arthritis In Vivo and Baseline Signaling Profile Associates With Treatment Response
por: Palmroth, Maaria, et al.
Publicado: (2021)

Editorial: Termination of pro-inflammatory signaling and its dysregulation in autoimmune diseases
por: Huber, René, et al.
Publicado: (2023)

Characterization of JAK1 Pseudokinase Domain in Cytokine Signaling
por: Raivola, Juuli, et al.
Publicado: (2019)

Editorial: Autoimmune Blistering Diseases
por: Kowalewski, Cezary, et al.
Publicado: (2020)

Editorial: Autoimmune pre-disease
por: Hundt, Jennifer E., et al.
Publicado: (2023)

Editorial: Therapeutic potential of innate and innate-like effector lymphocytes in autoimmune and inflammatory diseases
por: Wu, Lan, et al.
Publicado: (2023)

An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
por: Lensing, Maddison, et al.
Publicado: (2022)

Editorial: Role of Epigenetics in Autoimmune Diseases
por: Dolcino, Marzia, et al.
Publicado: (2020)

Editorial: Adhesion molecules and autoimmune diseases
por: Fan, Zhichao, et al.
Publicado: (2022)

The Janus kinases (Jaks)
por: Yamaoka, Kunihiro, et al.
Publicado: (2004)

Editorial: Innate Immunity Pathways in Autoimmune Diseases
por: Zouali, Moncef, et al.
Publicado: (2019)

Editorial: Autoimmune blistering diseases, volume II
por: Li, Xiaoguang, et al.
Publicado: (2023)

Editorial: Autophagy in Autoimmunity
por: Zhou, Xu-jie, et al.
Publicado: (2019)

Editorial: Skin Autoimmunity
por: Kridin, Khalaf, et al.
Publicado: (2021)

SOCS-JAK-STAT inhibitors and SOCS mimetics as treatment options for autoimmune uveitis, psoriasis, lupus, and autoimmune encephalitis
por: Pandey, Rahul, et al.
Publicado: (2023)

Calcineurin B in CD4(+) T Cells Prevents Autoimmune Colitis by Negatively Regulating the JAK/STAT Pathway
por: Mencarelli, Andrea, et al.
Publicado: (2018)

Editorial: Modulating Cytokines as Treatment for Autoimmune Diseases and Cancer
por: Mortier, Erwan, et al.
Publicado: (2020)

Editorial: Targeting Angiogenesis to Treat Autoimmune Diseases and Cancer
por: Rahat, Michal A., et al.
Publicado: (2020)

Editorial: The Role of Natural Killer Cells in Autoimmune Diseases
por: Fierabracci, Alessandra, et al.
Publicado: (2021)

Editorial: The Role of Nuclear Molecules in the Pathogenesis of Autoimmune Disease
por: Pisetsky, David S., et al.
Publicado: (2021)

Editorial: Immune Monitoring Responses in Renal Autoimmune Diseases
por: Teng, Y. K. Onno, et al.
Publicado: (2021)

Editorial: Immunomodulatory Roles of Extracellular Vesicles in Autoimmune Diseases
por: Gu, Zhifeng, et al.
Publicado: (2022)

Editorial: Stem cell transplantation in autoimmune diseases (AID)
por: Schmalzing, Marc, et al.
Publicado: (2023)

Editorial: Biomarkers in autoimmune diseases of the central nervous system
por: Zhang, Yin-Xi, et al.
Publicado: (2023)

Editorial: Importance of cytokines and receptor members from the IL-1 family in the context of chronic autoimmune inflammatory diseases
por: Talaat, Roba M., et al.
Publicado: (2022)

Inhibition of T-cell activity in alopecia areata: recent developments and new directions
por: Passeron, Thierry, et al.
Publicado: (2023)

Editorial: The Role of the Environment in Autoimmunity
por: Pestka, James J., et al.
Publicado: (2021)

Editorial: Pathogens, Pathobionts, and Autoimmunity
por: Spatz, Linda A., et al.
Publicado: (2021)

Editorial: The complement system in autoimmunity
por: Wu, Eveline Y., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_am155p1s2hngp42heck81340ku